1. Abe T. Acute sensorineural hearing loss in low frequencies. Otolaryngol (Tokyo). 1982; 54:385–92.
2. Yamasoba T, Sugasawa M, Kikuchi S, Yagi M, Harada T. An electrocochleographic study of acute low-tone sensorineural hearing loss. Eur Arch Otorhinolaryngol. 1993; 250(7):418–22.
3. Yamasoba T, Kikuchi S, Sugasawa M, Yagi M, Harada T. Acute low-tone sensorineural hearing loss without vertigo. Arch Otolaryngol Head Neck Surg. 1994; 120(5):532–5.
4. Imamura S, Nozawa I, Imamura M, Murakami Y. Clinical observations on acute low-tone sensorineural hearing loss. Survey and analysis of 137 patients. Ann Otol Rhinol Laryngol. 1997; 106(9):746–50.
5. Choi HG, Park KH, Seo JH, Kim DK, Yeo SW, Park SN. Clinical and audiologic characteristics of acute low-tone sensorineural hearing loss: Therapeutic response and prognosis. Korean J Audiol. 2011; 15(1):8–13.
6. Oh YS, Kim KS, Choi H, Kim KJ. Acute low tone sensorineural hearing loss: Consideration for progression to Meniere’s disease. Res Vestib Sci. 2010; 9(1):16–20.
7. Im GJ, Kim SK, Choi J, Song JJ, Chae SW, Jung HH. Analysis of audio-vestibular assessment in acute low-tone hearing loss. Acta Otolaryngol. 2016; 136(7):649–54.
8. Yoshida T, Sone M, Kitoh R, Nishio SY, Ogawa K, Kanzaki S, et al. Idiopathic sudden sensorineural hearing loss and acute low-tone sensorineural hearing loss: A comparison of the results of a nationwide epidemiological survey in Japan. Acta Otolaryngol. 2017; 137(sup565):S38–43.
9. Nozawa I, Imamura S, Mizukoshi A, Honda H, Okamoto Y. Clinical study of acute low-tone sensorineural hearing loss: Survey and analysis of glycerol test and orthostatic test. Ann Otol Rhinol Laryngol. 2002; 111(2):160–4.
10. Noguchi Y, Nishida H, Tokano H, Kawashima Y, Kitamura K. Comparison of acute low-tone sensorineural hearing loss versus Meniere’s disease by electrocochleography. Ann Otol Rhinol Laryngol. 2004; 113(3 Pt 1):194–9.
11. Wu CL, Young YH. Vestibular evoked myogenic potentials in acute low-tone sensorineural hearing loss. Laryngoscope. 2004; 114(12):2172–5.
12. Wang CT, Fang KM, Young YH, Cheng PW. Vestibular-evoked myogenic potential in the prediction of recovery from acute lowtone sensorineural hearing loss. Ear Hear. 2010; 31(2):289–95.
13. Limviriyakul S, Luangsawang C, Suvansit K, Prakairungthong S, Thongyai K, Atipas S. Video head impulse test and caloric test in definite Ménière’s disease. Eur Arch Otorhinolaryngol. 2020; 277(3):679–86.
14. Conte G, Lo Russo FM, Calloni SF, Sina C, Barozzi S, Di Berardino F, et al. MR imaging of endolymphatic hydrops in Ménière’s disease: Not all that glitters is gold. Acta Otorhinolaryngol Ital. 2018; 38(4):369–76.
15. Boegle R, Gerb J, Kierig E, Becker-Bense S, Ertl-Wagner B, Dieterich M, et al. Intravenous delayed gadolinium-enhanced MR imaging of the endolymphatic space: A methodological comparative study. Front Neurol. 2021; 12:647296.
16. Lin KT, Lu CJ, Young YH. Magnetic resonance imaging: Role on diagnosing all types of endolymphatic hydrops. J Formos Med Assoc. 2022; 121(7):1325–33.
17. Fuse T, Aoyagi M, Funakubo T, Sakakibara A, Yoshida S. Short-term outcome and prognosis of acute low-tone sensorineural hearing loss by administration of steroid. ORL J Otorhinolaryngol Relat Spec. 2002; 64(1):6–10.
18. Morita S, Suzuki M, Iizuka K. A comparison of the short-term outcome in patients with acute low-tone sensorineural hearing loss. ORL J Otorhinolaryngol Relat Spec. 2010; 72(6):295–9.
19. Suzuki M, Otake R, Kashio A. Effect of corticosteroids or diuretics in low-tone sensorineural hearing loss. ORL J Otorhinolaryngol Relat Spec. 2006; 68(3):170–6.
20. Chang J, Yum G, Im HY, Jung JY, Rah YC, Choi J. Short-term outcomes of acute low-tone sensorineural hearing loss according to treatment modality. J Audiol Otol. 2016; 20(1):47–52.
21. Park MJ, Kim SH, Kim SS, Yeo SG. Clinical characteristics and short-term outcomes of acute low frequency sensorineural hearing loss with vertigo. Clin Exp Otorhinolaryngol. 2018; 11(2):96–101.
22. Morita S, Nakamaru Y, Fujiwara K, Iizuka K, Masuya M, Homma A, et al. The short- and long-term outcome of intratympanic steroid therapy as a salvage treatment for acute low-tone sensorineural hearing loss without episodes of vertigo. Audiol Neurootol. 2016; 21(3):132–40.
23. Jung AR, Kim MG, Kim SS, Kim SH, Yeo SG. Clinical characteristics and prognosis of low frequency sensorineural hearing loss without vertigo. Acta Otolaryngol. 2016; 136(2):159–63.
24. Fushiki H, Junicho M, Aso S, Watanabe Y. Recurrence rate of idiopathic sudden low-tone sensorineural hearing loss without vertigo: A long-term follow-up study. Otol Neurotol. 2009; 30(3):295–8.
25. Fushiki H, Junicho M, Kanazawa Y, Aso S, Watanabe Y. Prognosis of sudden low-tone loss other than acute low-tone sensorineural hearing loss. Acta Otolaryngol. 2010; 130(5):559–64.
26. Oishi N, Inoue Y, Saito H, Kanzaki S, Kanzaki J, Ogawa K. Long-term prognosis of low-frequency hearing loss and predictive factors for the 10-year outcome. Otolaryngol Head Neck Surg. 2010; 142(4):565–9.
27. Kim H, Lee H, Kim YC, Park E, Choi J, Rah YC, et al. Update on clinical manifestation in acute low-tone hearing loss. Korean J Otorhinolaryngol-Head Neck Surg. 2020; 63(9):403–8.